These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17112841)

  • 21. Immunological status in three patients, thirty years after living related renal transplantation: antibody production in long-term survivors.
    Miyamoto N; Ishida H; Furusawa M; Shimizu T; Shirakawa H; Omoto K; Tanabe K; Toma H
    Transpl Immunol; 2008 Feb; 18(4):368-72. PubMed ID: 18158125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survey of renal transplantation in Slovenia.
    Kandus A; Arnol M; Bren AF
    Ther Apher Dial; 2009 Aug; 13(4):264-7. PubMed ID: 19695056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidneys from deceased donors more than 75 years perform acceptably after transplantation.
    Foss A; Heldal K; Scott H; Foss S; Leivestad T; Jørgensen PF; Scholz T; Midtvedt K
    Transplantation; 2009 May; 87(10):1437-41. PubMed ID: 19461478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A national program for nondirected kidney donation from living unrelated donors: the Philippine experience.
    Manauis MN; Pilar KA; Lesaca R; de Belen Uriarte R; Danguilan R; Ona E
    Transplant Proc; 2008 Sep; 40(7):2100-3. PubMed ID: 18790164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.
    Øien CM; Reisaeter AV; Leivestad T; Dekker FW; Line PD; Os I
    Transplantation; 2007 Mar; 83(5):600-6. PubMed ID: 17353781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incidence and risk factors of delayed graft function in 689 consecutive living unrelated donor renal transplantation.
    Ghods AJ; Savaj S; Abbasi M; Heidari H; Rokhsatyazdi H
    Transplant Proc; 2007 May; 39(4):846-7. PubMed ID: 17524828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipient.
    Herzig KA; Falk MC; Jonsson JR; Axelsen RA; Griffin AD; Hawley CM; Rigby RJ; Cobcroft R; Nicol DL; Powell EE; Johnson DW
    Transplantation; 2000 Jul; 70(1):149-52. PubMed ID: 10919592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early onset proteinuria after renal transplantation: a marker for allograft dysfunction.
    Ibis A; Altunoglu A; Akgül A; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
    Transplant Proc; 2007 May; 39(4):938-40. PubMed ID: 17524856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in serum creatinine levels and transplant year.
    Mizutani K; Terasaki P
    Clin Transpl; 2005; ():355-63. PubMed ID: 17424751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
    Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N
    Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deceased donor kidney transplantation in elderly patients: is there a difference in outcomes?
    Saidi RF; Kennealey PT; Elias N; Kawai T; Hertl M; Farrell M; Goes N; Hartono C; Tolkoff-Rubin N; Cosimi AB; Ko DS
    Transplant Proc; 2008 Dec; 40(10):3413-7. PubMed ID: 19100401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-risk constellation in living renal transplantation.
    Thorban S; Hüser N; Novotny A; Raggi MC; Matevossian E; Schwarznau A; Assfalg V; Kriner M; Stangl M
    Transplant Proc; 2007 Mar; 39(2):505-8. PubMed ID: 17362768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of donor age on renal allograft function and survival.
    Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
    Transplant Proc; 2009 Apr; 41(3):794-6. PubMed ID: 19376354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab.
    Beimler JH; Morath C; Schmidt J; Ovens J; Opelz G; Rahmel A; Zeier M; Süsal C
    Transplantation; 2009 Mar; 87(5):668-71. PubMed ID: 19295310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How can we increase living related donor renal transplantations?
    Nakamura Y; Konno O; Matsuno N; Yokoyama T; Kuzuoka K; Kihara Y; Taira S; Jojima Y; Akashi I; Iwamoto H; Hama K; Iwahori T; Ashizawa T; Kubota K; Tojimbara T; Nakajima I; Nagao T
    Transplant Proc; 2008 Sep; 40(7):2104-7. PubMed ID: 18790165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship of donor source and age on short- and long-term allograft survival in pediatric renal transplantation.
    Dale-Shall AW; Smith JM; McBride MA; Hingorani SR; McDonald RA
    Pediatr Transplant; 2009 Sep; 13(6):711-8. PubMed ID: 19207226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exchange living-donor kidney transplantation: merits and limitations.
    Huh KH; Kim MS; Ju MK; Chang HK; Ahn HJ; Lee SH; Lee JH; Kim SI; Kim YS; Park K
    Transplantation; 2008 Aug; 86(3):430-5. PubMed ID: 18698247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.